Allergol Int 2020 Jan 29
Dupilumab: Basic aspects and applications to allergic diseases.
Matsunaga K, Katoh N, Fujieda S, Izuhara K, Oishi K
Interleukin (IL)-4 and IL-13, signature type 2 cytokines, exert their actions by binding to two types of receptors sharing the IL-4R a chain (IL-4Ra). ...
Read More
Source: PubMed
J Allergy Clin Immunol Pract 2020 Jan 29
Prenatal particulate matter exposure with skin barrier dysfunction affects offspring's atopic dermatitis: COCOA study.
Lee E, Lee SY, Kim HC, Choi KY, Kim HB, Park MJ, Rhee ES, Yoon JS, Cho HJ, Jung S, Ahn K, Kim KW, Sheen YH, Suh DI, Hong SJ
Read More
Source: PubMed
Dermatol Ther (Heidelb) 2020 Jan 31
Qualitative Assessment of Adult Patients' Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study.
Falissard B, Simpson EL, Guttman-Yassky E, Papp KA, Barbarot S, Gadkari A, Saba G, Gautier L, Abbe A, Eckert L
Atopic dermatitis (AD) is an incurable, inflammatory skin disease characterized by skin barrier disruption and immune dysregulation. Although AD is co ...
Read More
Source: PubMed
Handb Exp Pharmacol 2020 Feb 01
Dermatology Part 2: Ichthyoses and Psoriasis.
Sticherling M
Acute and chronic inflammatory skin diseases are frequent in childhood and may be hereditary or acquired. In this context, ichthyosis is rather a symp ...
Read More
Source: PubMed
J. Am. Acad. Dermatol. 2020 Jan 28
Placebo tailoring improves patient satisfaction of treatment plans in atopic dermatitis.
Bashyam AM, Cuellar-Barboza A, Ghamrawi RI, Feldman SR
Read More
Source: PubMed
